NEKTAR THERAPEUTICS (NKTR) Operating income 2016–2025
NEKTAR THERAPEUTICS (NKTR) annual operating income history from SEC filings — each fiscal year as reported.
-$140.1MFY2025 · since FY2016: -$112.9M → -$140.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$140.1M | -33.2% |
| FY2024 | -$105.2M | +60.1% |
| FY2023 | -$263.7M | +29.9% |
| FY2022 | -$376.2M | +15.7% |
| FY2021 | -$446.1M | -4.9% |
| FY2020 | -$425.1M | +3.4% |
| FY2019 | -$440.0M | -164.0% |
| FY2018 | $687.9M | +1253.4% |
| FY2017 | -$59.6M | +47.2% |
| FY2016 | -$112.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice